Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study

Background. About one third of patients with TIMI 3 after reperfusion have evidence of microvascular obstruction (MO) which represents an independent predictor of myocardial wall rupture. This explains all efforts made to prevent MO. Magnetic resonance imaging (MRI) has proved to be particularly use...

Full description

Bibliographic Details
Main Authors: Tiziano Gherli, Peter Knoll, Antonello Zoni
Format: Article
Language:English
Published: Touch Medical Media 2010-05-01
Series:Heart International
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/hi/article/view/1882
_version_ 1818282144668057600
author Tiziano Gherli
Peter Knoll
Antonello Zoni
author_facet Tiziano Gherli
Peter Knoll
Antonello Zoni
author_sort Tiziano Gherli
collection DOAJ
description Background. About one third of patients with TIMI 3 after reperfusion have evidence of microvascular obstruction (MO) which represents an independent predictor of myocardial wall rupture. This explains all efforts made to prevent MO. Magnetic resonance imaging (MRI) has proved to be particularly useful in detecting MO. The aim of this study was to evaluate with MRI if different fibrinolytic regimens in acute myocardial infarction display different effects on left ventricle (LV) volumes and ejection fraction (EF), as well as on myocardial infarct size (MIsz) and MO. Methods. Twenty male patients, mean age 58 years, affected by acute myocardial infarction, ten anterior and ten inferior, were treated with: full dose reteplase in ten, and half dose reteplase plus full dose abciximab (R+Abcx) in the other ten patients. In the fourth day after hospital admission, MRI STIR T2 images were used to quantify MIsz, while 2dflash cineloops were used after the injection of gadolinium, to quantify LV volumes, EF and to detect MO. Results. LV EF was higher in R+Abcx 51±10 than in reteplase 41±8. MIsz was similar in both treatment groups: however a close relationship was present between MIsz and EF in the reteplase group indicating that the greater the MIsz the lower the EF. In R+Abcx this relationship was no longer present, suggesting a protective effect of the drug on microcirculation. In fact extensive MO was present in 25% of all cases, 80% of which in the reteplase group while only 20% in R+Abcx. Conclusion. R+Abcx prevents MO: compared to traditional fibrinolytic therapy it allows better LV function and most likely improved long term survival.
first_indexed 2024-12-13T00:16:21Z
format Article
id doaj.art-0d139004537a4ef09b0a053df4c051a7
institution Directory Open Access Journal
issn 1826-1868
2036-2579
language English
last_indexed 2024-12-13T00:16:21Z
publishDate 2010-05-01
publisher Touch Medical Media
record_format Article
series Heart International
spelling doaj.art-0d139004537a4ef09b0a053df4c051a72022-12-22T00:05:47ZengTouch Medical MediaHeart International1826-18682036-25792010-05-0121546510.4081/hi.2006.54Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance studyTiziano GherliPeter KnollAntonello ZoniBackground. About one third of patients with TIMI 3 after reperfusion have evidence of microvascular obstruction (MO) which represents an independent predictor of myocardial wall rupture. This explains all efforts made to prevent MO. Magnetic resonance imaging (MRI) has proved to be particularly useful in detecting MO. The aim of this study was to evaluate with MRI if different fibrinolytic regimens in acute myocardial infarction display different effects on left ventricle (LV) volumes and ejection fraction (EF), as well as on myocardial infarct size (MIsz) and MO. Methods. Twenty male patients, mean age 58 years, affected by acute myocardial infarction, ten anterior and ten inferior, were treated with: full dose reteplase in ten, and half dose reteplase plus full dose abciximab (R+Abcx) in the other ten patients. In the fourth day after hospital admission, MRI STIR T2 images were used to quantify MIsz, while 2dflash cineloops were used after the injection of gadolinium, to quantify LV volumes, EF and to detect MO. Results. LV EF was higher in R+Abcx 51±10 than in reteplase 41±8. MIsz was similar in both treatment groups: however a close relationship was present between MIsz and EF in the reteplase group indicating that the greater the MIsz the lower the EF. In R+Abcx this relationship was no longer present, suggesting a protective effect of the drug on microcirculation. In fact extensive MO was present in 25% of all cases, 80% of which in the reteplase group while only 20% in R+Abcx. Conclusion. R+Abcx prevents MO: compared to traditional fibrinolytic therapy it allows better LV function and most likely improved long term survival.http://www.pagepress.org/journals/index.php/hi/article/view/1882Magnetic resonance, Myocardial infarction, Microvascular obstruction
spellingShingle Tiziano Gherli
Peter Knoll
Antonello Zoni
Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study
Heart International
Magnetic resonance, Myocardial infarction, Microvascular obstruction
title Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study
title_full Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study
title_fullStr Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study
title_full_unstemmed Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study
title_short Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance study
title_sort microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction comparison of reteplase vs reteplase abciximab a cardiovascular magnetic resonance study
topic Magnetic resonance, Myocardial infarction, Microvascular obstruction
url http://www.pagepress.org/journals/index.php/hi/article/view/1882
work_keys_str_mv AT tizianogherli microvascularobstructionaftersuccessfulfibrinolytictherapyinacutemyocardialinfarctioncomparisonofreteplasevsreteplaseabciximabacardiovascularmagneticresonancestudy
AT peterknoll microvascularobstructionaftersuccessfulfibrinolytictherapyinacutemyocardialinfarctioncomparisonofreteplasevsreteplaseabciximabacardiovascularmagneticresonancestudy
AT antonellozoni microvascularobstructionaftersuccessfulfibrinolytictherapyinacutemyocardialinfarctioncomparisonofreteplasevsreteplaseabciximabacardiovascularmagneticresonancestudy